Super active surveillance for low-risk prostate cancer - Opinion: No

Ghodoussipour, Saum; Lebastchi, Amir; Pinto, Peter; Berger, Andre

Ghodoussipour, Saum; Lebastchi, Amir; Pinto, Peter; Berger, Andre.

Ghodoussipour, Saum; University of Southern California. Department of Urology. Los Angeles. US
Lebastchi, Amir; National Cancer Institute. Bethesda. US
Pinto, Peter; National Cancer Institute. Bethesda. US
Berger, Andre; University of Southern California. Department of Urology. Los Angeles. US

Int. braz. j. urol ; 45(2): 215-219, Mar.-Apr. 2019.

Article in English | LILACS | ID: biblio-1040054

Subject(s)

Humans; Male; Prostatic Neoplasms/epidemiology; Population Surveillance; Watchful Waiting/methods; Prostatectomy/methods; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/pathology; Biopsy/methods; Magnetic Resonance Imaging/methods; Risk; Prostate-Specific Antigen; Disease Progression; Ablation Techniques/methods

Prostatic Neoplasms; Risk Reduction Behavior; Therapeutics; Watchful Waiting

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Prostatic Neoplasms / Population Surveillance / Watchful Waiting Type of study: Diagnostic study / Etiology study / Risk factors / Screening study Limits: Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2019 Type: Article Affiliation country: United States Institution/Affiliation country: National Cancer Institute/US / University of Southern California/US

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google